Selective Reductions in Plasma A 1-42 in Healthy Elderly Subjects During Longitudinal Follow-Up: A Preliminary Report
about
Amyloid-associated depression: a prodromal depression of Alzheimer disease?Biological markers of amyloid beta-related mechanisms in Alzheimer's diseaseMaternal Malnutrition in the Etiopathogenesis of Psychiatric Diseases: Role of Polyunsaturated Fatty AcidsBlood-Based Proteomic Biomarkers of Alzheimer's Disease PathologyBiomarkers for cognitive impairment and dementia in elderly people.Plasma beta-amyloid and duration of Alzheimer's disease in adults with Down syndrome.Soluble amyloid-β levels and late-life depressionDepression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele.Plasma ß-amyloid and cognitive decline.Interactions between the apolipoprotein E ε4 allele status and adverse childhood experiences on depressive symptoms in older adultsBiological markers for early detection and pharmacological treatment of Alzheimer's disease.Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants.Candidate genes for Alzheimer's disease are associated with individual differences in plasma levels of beta amyloid peptides in adults with Down syndrome.Change in plasma Aß peptides and onset of dementia in adults with Down syndrome.Biomarkers associated with delirium in critically ill patients and their relation with long-term subjective cognitive dysfunction; indications for different pathways governing delirium in inflamed and noninflamed patients.Fluid biomarkers in Alzheimer disease.Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer's disease.Peripheral Abeta subspecies as risk biomarkers of Alzheimer's diseasePlasma Amyloid-β Peptides and Homocysteine in Depression in the Homebound Elderly.Elevated plasma beta-amyloid peptide Abeta(42) levels, incident dementia, and mortality in Down syndromePlasma amyloid-β as a predictor of dementia and cognitive decline: a systematic review and meta-analysis.Circulating immune complexes of Abeta and IgM in plasma of patients with Alzheimer's disease.Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults.Plasma amyloid-β levels and prognosis in incident dementia cases of the 3-City StudySerum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer's Disease.Aspects of beta-amyloid as a biomarker for Alzheimer's disease.Meta-analysis of plasma amyloid-β levels in Alzheimer's disease.Biomarkers for the Early Detection and Progression of Alzheimer's Disease.Toward a plasma marker for Alzheimer disease: some progress, but still a long way to go.Association of Plasma β-Amyloid with Cognitive Performance and Decline in Chronic Kidney Disease.Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study.
P2860
Q22253023-0B0CDE62-C327-43FB-8EB8-676B28D567EEQ24622136-8A7F8C3B-D50C-454A-A67E-CC268D1D09A8Q26740518-C46D96C8-2662-453A-BDE9-97C60EC6F850Q26774743-31F15EE1-2788-46A9-A9D3-018A3B411EC9Q30370745-6927F0A7-5B72-43E8-8DC0-1D323DFE3837Q33609644-6E177466-F13A-4F06-AF5E-7617F7B1BAECQ33933220-1CBA2CB4-4624-41EB-BB10-287FBED63CC3Q34056793-2E7C768E-35AC-4214-BBBA-EF5CF0F6BD1AQ34424794-DA4456E8-B40B-41D5-AA53-B984B94D1993Q35024426-A6813AA8-8CD3-4FFB-BD09-23C6D9B07EEFQ35237100-41615F70-7C32-4F4A-B741-4398FC9D62C8Q35601036-72E74F43-31CF-4324-8AC8-4A986FDA9754Q36037548-BCCB0E35-1D80-489F-AF78-547F56EAA95AQ36064807-E1C3CC67-F9D8-49BE-A167-681A7BD61B8EQ36073017-9F4D7771-A5FE-4240-B94B-905D89EE9FC7Q36186513-69C3A265-5A17-48B0-9E7A-5F6EF50E64F8Q36825209-BE98EBC2-7F1E-41E5-96C1-67204BFDA98AQ36893677-3C97F985-6463-4630-A194-B48F3C9B7F9DQ36919567-4476038C-A7C9-41F7-9C19-BD172D36728FQ36983170-D108F478-04B4-45E1-90A8-658D2B651088Q37169576-3B293E2B-DB99-49E7-95C2-42E4D3CFF66EQ37238681-B32E4830-30D3-487A-BD34-23EB9FF96584Q37259576-7F18C53D-3AFB-431E-A0E9-CBB037A9C576Q37693190-C7E4231E-4D8A-44D7-86C4-C876D6169903Q37716145-F824BFC3-0582-4D3B-91E0-1765D867DF30Q37755129-305B6D12-0B06-4360-AD2C-FD86CCBBD22EQ37895050-35DFE9EB-F76A-4257-9773-3677230396F7Q38979999-C8DEA55E-E5B8-41DE-BDB2-27CB842F6A36Q42739495-1B55A4F6-C105-4998-B1D1-49A4C12E0CDCQ48450061-30CA9FB4-9695-4425-B7B7-93838FB58DABQ55516241-7E964430-24F1-469C-A9AF-3584B619FEA1
P2860
Selective Reductions in Plasma A 1-42 in Healthy Elderly Subjects During Longitudinal Follow-Up: A Preliminary Report
description
im Oktober 2005 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2005
@uk
name
Selective Reductions in Plasma ...... ollow-Up: A Preliminary Report
@en
Selective Reductions in Plasma ...... ollow-Up: A Preliminary Report
@nl
type
label
Selective Reductions in Plasma ...... ollow-Up: A Preliminary Report
@en
Selective Reductions in Plasma ...... ollow-Up: A Preliminary Report
@nl
prefLabel
Selective Reductions in Plasma ...... ollow-Up: A Preliminary Report
@en
Selective Reductions in Plasma ...... ollow-Up: A Preliminary Report
@nl
P1476
Selective Reductions in Plasma ...... ollow-Up: A Preliminary Report
@en
P304
P356
10.1176/APPI.AJGP.13.10.914
P577
2005-10-01T00:00:00Z